Ibaraki, Japan

Toshio Nakamura


Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Ibaraki, JA (1976)
  • Nishinomiya, JP (1987)

Company Filing History:


Years Active: 1976-1987

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Toshio Nakamura

Introduction

Toshio Nakamura is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. With a total of two patents to his name, his work has garnered attention in the scientific community.

Latest Patents

Nakamura's latest patents include innovative compounds such as Carbacyclin analogs. These compounds are characterized by a specific formula that includes various functional groups, demonstrating strong anti-ulcerous and antithrombotic actions. They are particularly useful in the treatment of ulcers and thrombosis. Additionally, he has developed pharmaceutical compositions that ensure controlled rates of gastrointestinal absorption, utilizing absorption depressive agents derived from natural sources.

Career Highlights

Toshio Nakamura is currently associated with Sumitomo Chemical Company, Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating effective pharmaceutical solutions that address critical health issues.

Collaborations

Nakamura has collaborated with esteemed colleagues such as Masami Muraoka and Akihiko Sugie. Their combined expertise has contributed to the successful development of innovative pharmaceutical products.

Conclusion

Toshio Nakamura's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…